Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Grid Therapeutics Signs Exclusive Agreement to Develop a Novel Immuno-Oncology Antibody

pharmaceutical-technologyAugust 23, 2017

Tag: Grid Therapeutics , tumor , antibody

PharmaSources Customer Service